To describe the etiology and treatment outcomes of choroidal neovascularization (CNV) in a pediatric population with intravitreal anti-vascular endothelial growth factors (VEGF)
Methods:
Retrospective single center interventional case series. A total of 26 eyes of 23 consecutive pediatric patients with CNV of various etiologies were treated with intravitreal injection of anti-VEGF agents.
Results:
There were 15 males (65.2%) and eight females (34.8%), diagnosed with CNV during the study period. The mean age at presentation with CNV was 11.7 ± 3.3 years, (range 4–16 years) and the mean follow was 28.1 ± 18 months, (range 8–72 months). Inflammatory CNV was the most common etiology. The mean best corrected visual acuity (BCVA) and mean central macular thickness (CMT) at presentation, were logMAR 0.8 ± 0.3 and 367.6 ± 134.8 µm respectively. At the final visit, CNV in all eyes remained regressed with significant improvement in mean BCVA to logMAR 0.4 ± 0.4 (p < 0.0001) and mean CMT to 242.5 ± 82.4 µm (p < 0.0001). A mean of two intravitreal injections per eye was required for CNV regression.
Conclusion:
Intravitreal anti-VEGF therapy for pediatric CNV is an effective treatment in majority of affected eyes.
SivaprasadSMooreAT. Choroidal neovascularisation in children. Br J Ophthalmol2008; 92(4): 451–454.
2.
VeroneseCMaioloCHuangD, et al. Optical coherence tomography angiography in pediatric choroidal neovascularization. Am J Ophthalmol Case Rep2016; 2: 37–40.
SpitzerMGrisantiSBartz-SchmidtKU, et al. Choroidal neovascularization in retinochoroidal coloboma: thermal laser treatment achieves long-term stabilization of visual acuity. Eye2006; 20(8): 969–972.
5.
SearsJCaponeAJrAabergTSr, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology1999; 106(5): 920–924.
6.
MimouniKFBresslerSBBresslerNM. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol2003; 135(6): 900–902.
7.
GiansantiFVirgiliGVaranoM, et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina2005; 25(5): 590–596.
8.
RishiPVenkataramanARishiE. Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol2011; 59(1): 62–64.
9.
KozakIMansourADiazRI, et al. Outcomes of treatment of pediatric choroidal neovascularization with intravitreal antiangiogenic agents. Retina2014; 34(10): 2044–2052.
10.
HenryCRSiskRATzuJH, et al. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases. J AAPOS2015; 19(6): 541–548.
11.
PadhiTRAndersonBJAbbeyAM, et al. Choroidal neovascular membrane in paediatric patients: clinical characteristics and outcomes. Br J Ophthalmol2018; 102: 1232–1237.
12.
DʼsouzaPRanjanRBabuU, et al. Inflammatory choroidal neovascular membrane: long-term visual and anatomical outcomes after intravitreal anti-vascular endothelial growth factor therapy. Retina2018; 38(7): 1307–1315.
13.
KnapeRMZavaletaEMClarkCL, et al. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus2011; 15(1): 87–90.
14.
LeeEJMavrikakisIFongK, et al. Primary peripapillary membrane in an 8-year-old boy. Eye2006; 20(3): 379–380.
15.
CohenSYLarocheALeguenY, et al. Etiology of choroidal neovascularization in young patients. Ophthalmology1996; 103(8): 1241–1244.
16.
DhingraNKellySMajidMA, et al. Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment. Indian J Ophthalmol2010; 58(1): 3–10.
17.
RishiPGuptaARishiE, et al. Choroidal neovascularization in 36 eyes of children and adolescents. Eye2013; 27(10): 1158–1168.
18.
TabbaraKFChavisPSFreemanWR. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand1998; 76(6): 723–726.
19.
SoheilianMAletahaMYazdaniS, et al. Management of pediatric vogt-koyanagi- Harada (VKH)-associated panuveitis. Ocul Immunol Inflamm2006; 14(2): 91–98.
20.
Abu El-AsrarAMAl-KharashiASAldibhiH, et al. Vogt-Koyanagi-Harada disease in children. Eye2008; 22(9): 1124–1131.
21.
DeshpandeSDeshpandeMParitekarP. An unusual case of unilateral multifocal choroiditis in a young male. Niger J Ophthalmol2015; 23(2): 71.
22.
VyasJPGiridharA. Choroidal neovascular membrane In paediatric population – etiology, clinical features and visual outcome. Kerala J Ophthalmol2011; XXIII(1): 52–55.
23.
BarthTZemanFHelbigH, et al. Etiology and treatment of choroidal neovascularization in pediatric patients. Eur J Ophthalmol2016; 26(5): 388–393.
24.
PatelRCGaoSSZhangM, et al. Optical coherence tomography angiography of choroidal neovascularization in four inherited retinal dystrophies. Retina2016; 36(12): 2339–2347.
25.
RobinsonDTiedemanJ. Choroideremia associated with a subretinal neovascular membrane. Retina1987; 7(2): 70–74.
